INBX vs ZYME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

INBX

49.6
AI Score
VS
INBX Wins

ZYME

49.1
AI Score

Investment Advisor Scores

INBX

50score
Recommendation
HOLD

ZYME

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric INBX ZYME Winner
Forward P/E 0 22.0264 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% -91.1% ZYME
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 49.6/100 49.1/100 INBX
Profit Margin 0.0% -126.3% INBX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

INBX 1M: -16.6% · 3M: -36.8% ZYME 1M: -16.5% · 3M: -17.5%

Current Technical Phase

INBX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.0%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $81.39

ZYME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 35

RSI (14): 35.4 · Price: $21.96

Fundamentals Snapshot

Metric INBX ZYME
Market Cap
Forward P/E -13.0 42.7
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% -0.9%
Gross Margin -77.0% -0.7%
Operating Margin -94.7% -19.6%
EPS -8.98 -1.37
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, INBX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.